These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 16510370

  • 1. Effects of fluvastatin slow-release (XL 80 mg) versus simvastatin (20 mg) on the lipid triad in patients with type 2 diabetes.
    Bevilacqua M, Righini V, Barrella M, Vago T, Chebat E, Dominguez LJ.
    Adv Ther; 2005; 22(6):527-42. PubMed ID: 16510370
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and tolerability of fluvastatin extended-release delivery system: a pooled analysis.
    Ballantyne CM, Pazzucconi F, Pintó X, Reckless JP, Stein E, McKenney J, Bortolini M, Chiang YT.
    Clin Ther; 2001 Feb; 23(2):177-92. PubMed ID: 11293552
    [Abstract] [Full Text] [Related]

  • 3. Effect of fluvastatin slow-release on low density lipoprotein (LDL) subfractions in patients with type 2 diabetes mellitus: baseline LDL profile determines specific mode of action.
    Winkler K, Abletshauser C, Hoffmann MM, Friedrich I, Baumstark MW, Wieland H, März W.
    J Clin Endocrinol Metab; 2002 Dec; 87(12):5485-90. PubMed ID: 12466341
    [Abstract] [Full Text] [Related]

  • 4. Effects of fluvastatin extended-release (80 mg) alone and in combination with ezetimibe (10 mg) on low-density lipoprotein cholesterol and inflammatory parameters in patients with primary hypercholesterolemia: a 12-week, multicenter, randomized, open-label, parallel-group study.
    Alvarez-Sala LA, Cachofeiro V, Masana L, Suarez C, Pinilla B, Plana N, Trias F, Moreno MA, Gambus G, Lahera V, Pintó X.
    Clin Ther; 2008 Jan; 30(1):84-97. PubMed ID: 18343245
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Fluvastatin slow-release lowers platelet-activating factor acetyl hydrolase activity: a placebo-controlled trial in patients with type 2 diabetes.
    Winkler K, Abletshauser C, Friedrich I, Hoffmann MM, Wieland H, März W.
    J Clin Endocrinol Metab; 2004 Mar; 89(3):1153-9. PubMed ID: 15001601
    [Abstract] [Full Text] [Related]

  • 7. Comparisons of effects of statins (atorvastatin, fluvastatin, lovastatin, pravastatin, and simvastatin) on fasting and postprandial lipoproteins in patients with coronary heart disease versus control subjects.
    Schaefer EJ, McNamara JR, Tayler T, Daly JA, Gleason JL, Seman LJ, Ferrari A, Rubenstein JJ.
    Am J Cardiol; 2004 Jan 01; 93(1):31-9. PubMed ID: 14697462
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparison of treatment with fluvastatin extended-release 80-mg tablets and immediate-release 40-mg capsules in patients with primary hypercholesterolemia.
    Isaacsohn JL, LaSalle J, Chao G, Gonasun L.
    Clin Ther; 2003 Mar 01; 25(3):904-18. PubMed ID: 12852707
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and safety of extended-release fluvastatin in Turkish patients with hypercholesterolaemia: TULIPS (Turkish Lipid Study).
    Ilerigelen B, Uresin Y, San M, Kültürsay H, Güneri S, Serdar OA, Güleç S, Pençedemir H, TULIPS Investigators.
    Curr Med Res Opin; 2007 May 01; 23(5):1093-102. PubMed ID: 17519076
    [Abstract] [Full Text] [Related]

  • 11. Metabolic effects of fluvastatin extended release 80 mg and atorvastatin 20 mg in patients with type 2 diabetes mellitus and low serum high-density lipoprotein cholesterol levels: a 4-month, prospective, open-label, randomized, blinded-end point (probe) trial.
    Bevilacqua M, Guazzini B, Righini V, Barrella M, Toscano R, Chebat E.
    Curr Ther Res Clin Exp; 2004 Jul 01; 65(4):330-44. PubMed ID: 24672088
    [Abstract] [Full Text] [Related]

  • 12. Comparison of fluvastatin + fenofibrate combination therapy and fluvastatin monotherapy in the treatment of combined hyperlipidemia, type 2 diabetes mellitus, and coronary heart disease: a 12-month, randomized, double-blind, controlled trial.
    Derosa G, Cicero AE, Bertone G, Piccinni MN, Ciccarelli L, Roggeri DE.
    Clin Ther; 2004 Oct 01; 26(10):1599-607. PubMed ID: 15598476
    [Abstract] [Full Text] [Related]

  • 13. Comparison of lipid-lowering effects of low-dose fluvastatin and conventional-dose gemfibrozil in patients with primary hypercholesterolemia.
    Betteridge DJ, Durrington PN, Fairhurst GJ, Jackson G, McEwan MS, McInnes GT, Miller JP, Mir MA, Reckless JP, Rees-Jones DI.
    Am J Med; 1994 Jun 06; 96(6A):45S-54S. PubMed ID: 8017467
    [Abstract] [Full Text] [Related]

  • 14. [Variability of the hypolipidemic action of simvastatin and fluvastatin in patients with primary hyperlipoproteinemia].
    Tvorogova MG, Susekov AV, Semenova OA, Kukharchuk VV, Titov VN.
    Ter Arkh; 1998 Jun 06; 70(12):8-13. PubMed ID: 10067240
    [Abstract] [Full Text] [Related]

  • 15. Comparison of the efficacy and tolerability of fluvastatin extended-release and immediate-release formulations in the treatment of primary hypercholesterolemia: a randomized trial.
    Olsson AG, Pauciullo P, Soska V, Luley C, Pieters RE, Broda G, Palacios B, Fluvastatin Study Group.
    Clin Ther; 2001 Jan 06; 23(1):45-61. PubMed ID: 11219479
    [Abstract] [Full Text] [Related]

  • 16. Conversion from fluvastatin to simvastatin therapy at a dose ratio of 8 to 1: effect on serum lipid levels and cost.
    Rindone JP, Arriola G.
    Clin Ther; 1998 Jan 06; 20(2):340-6. PubMed ID: 9589824
    [Abstract] [Full Text] [Related]

  • 17. Differential effects of fluvastatin alone or in combination with ezetimibe on lipoprotein subfractions in patients at high risk of coronary events.
    Stojakovic T, de Campo A, Scharnagl H, Sourij H, Schmölzer I, Wascher TC, März W.
    Eur J Clin Invest; 2010 Mar 06; 40(3):187-94. PubMed ID: 20067513
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of fluvastatin in patients with non-insulin-dependent diabetes mellitus and hyperlipidemia.
    Knopp RH, Frohlich J, Jokubaitis LA, Dawson K, Broyles FE, Gomez-Coronado D.
    Am J Med; 1994 Jun 06; 96(6A):69S-78S. PubMed ID: 8017470
    [Abstract] [Full Text] [Related]

  • 19. [Effects of long acting fluvastatin on parameters of lipid metabolism in patients with type 2 diabetes and combined hyperlipidemia].
    Kozlov SG, Liakishev AA, Titov VN, Naumov VG.
    Kardiologiia; 2004 Jun 06; 44(10):60-3. PubMed ID: 15477793
    [No Abstract] [Full Text] [Related]

  • 20. Fluvastatin/fenofibrate vs. simvastatin/ezetimibe in patients with metabolic syndrome: different effects on LDL-profiles.
    Winkler K, Schewe T, Pütz G, Odünc N, Schäfer G, Siegel E, Geisen U, Abletshauser C, Hoffmann MM.
    Eur J Clin Invest; 2009 Jun 06; 39(6):463-70. PubMed ID: 19397693
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.